Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Tough adhesives for diverse wet surfaces
2017 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial
1992
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
2005 Standout
Thrombolysis for pulmonary embolism
1991
Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
1996 Standout
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
2014
Antithrombotic Therapy for VTE Disease
2016 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism
2002
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
1999 Standout
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Thrombolytic therapy of pulmonary embolism
2002
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Thrombolytic therapy for pulmonary embolism
2009
Fish Intake, Contaminants, and Human Health
2006 Standout
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Thrombolytic Therapy for Acute Pulmonary Embolism
2009
Streptokinase vs alteplase in massive pulmonary embolism: A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction
1997
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Thrombolytic Therapy: Current Status
1988
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Major Pulmonary Embolism
2002
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but Underused
2012
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Thrombolytic therapy of acute pulmonary embolism: Current status and future potential
1987
Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor‐1 mRNA in cultured human endothelial cells
1995 StandoutNobel
Novel management strategy for patients with suspected pulmonary embolism
2003
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
1996
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
2002 Standout
Regulation of Tissue Plasminogen Activator Expression
1989
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Comparative Efficacy of a Two-Hour Regimen of Streptokinase Versus Alteplase in Acute Massive Pulmonary Embolism: Immediate Clinical and Hemodynamic Outcome and One-Year Follow-Up 11This study was partly supported by grants from Programme Hospitalier de la Recherche Clinique (Ministère de la Santé Publique), Paris; Boehringer Ingelheim, Reims Cedex, France; and Hoechst France, Puteaux, France.
1998
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
1985
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
1987 Standout
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism
2004
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
The Effect of Dietary ω-3 Fatty Acids on Coronary Atherosclerosis
1999 Standout
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
1986
Part 9: Post–Cardiac Arrest Care
2010 Standout
Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases.
1988
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator
1990 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
1996
The histotoxicity of cyanoacrylates
1985
Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease.
1982
Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations
1987
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study.
1987
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
1979
Relationship between Doppler pulsatility index and direct femoral pressure measurements in the diagnosis of aortoiliac occlusive disease
1983
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
1991
Perioperative myocardial infarction complicating coronary bypass
1981
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM
1995
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The role of thrombolytic therapy in pulmonary embolism
2015
The branchial circulation and the gill epithelia in the Atlantic hagfish, Myxine glutinosa L.
1987
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
2014
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism.
1985
Works of Ragnar Hol being referenced
A Cineradiographic Study of the Central Circulation in the Hagfish, Myxine Glutinosa L
1960
Myocardial Infarction after Aortocoronary Bypass Surgery.The Incidence in 187 Consecutive Patients and the Late Postoperative Significance
1980
EVALUATION OF THE FUNCTIONAL IMPORTANCE OF ATHEROSCLEROTIC OBLITERATIONS IN THE AORTO‐ILIAC ARTERY BY PRESSURE/FLOW MEASUREMENTS
1972
Experimental Arteriovenous Fistulae
1961
Myocardial blood flow and metabolism in the diving seal
1982
Fibrinolytic capacity after venous stasis in patients undergoing aorto‐coronary by‐pass surgery. Relation to shunt occlusion
1983
A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary Embolism
1978